Judge Selects First Two Cases in Eli Lilly Testosterone Suit
June 23, 2017
A federal judge in Illinois has selected the first two cases to be tried in a Multi-District Litigation (MDL) case about the testosterone replacement drugs manufactured by pharmaceutical corporation Eli Lilly.
The cases of John DeBroka, Jr., and Tracy Garner will be the first to be heard in the trial concerning Eli Lilly’s Axiron testosterone therapy drug. Garner alleges that Axiron caused his heart attack; DeBroka alleges that Axiron caused his deep vein thrombosis.
The cases will be heard in January and March of 2018.
The MDL case consolidates nearly 6000 testosterone therapy cases. About two-thirds of those cases have been filed against AbbVie, a drug company that manufactures a testosterone replacement drug called AndroGel that can be applied topically.
Plaintiffs in all of the cases allege that the drug manufacturers marketed their products to men who did not actually need it, and that the drugs have caused serious and sometimes fatal health problems, such as heart attacks and strokes. At issue is whether testosterone therapy drugs cause the blood to clot.
A case against AbbVie about AndroGel ended in a mistrial, but will be recalled for trial in September.
Numerous other cases concerning the dangers of testosterone replacement drugs are currently working their way through the court system.
If you’ve had serious health problems as a result of using testosterone therapy drugs, contact the expert attorneys at TheLawFirm.com. We will advocate for your health.
Contact TheLawFirm.com to learn how we can help you.
Talk with aN Attorney now!
TheLawFirm.com’s award winning lawyers have been featured in over 50 radio and television interviews including:
Real lawyers, real results!
no recovery, no fee!